NEUROFIT
Private Company
Total funding raised: $2.5M
Overview
NEUROFIT is a long-established, specialized preclinical CRO focused exclusively on neuroscience, serving the biopharmaceutical industry since 1996. The company leverages over two decades of expertise and a stable core scientific team to provide flexible, client-integrated research services across a wide range of neurological, psychiatric, and inflammatory indications. Its business model is built on offering validated models, scientific guidance, and custom study designs to de-risk and accelerate early-stage drug development programs for its partners.
Technology Platform
A comprehensive and continuously updated suite of validated in vivo (animal) and in vitro (cell-based) disease models and behavioral tests for central and peripheral nervous system disorders, including neurology, psychiatry, cognition, and inflammation. Platform emphasizes extensive historical validation data and custom adaptation for client programs.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes against large, global contract research organizations (CROs) that offer broad preclinical services, and against other smaller, specialized neuroscience CROs. Differentiation is based on deep, focused expertise in neuroscience models, a stable scientific team, and a flexible, client-integrated partnership approach.